• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国绝经后女性血清25-羟基维生素D浓度与乳腺癌风险的关联

Association of Serum 25-Hydroxyvitamin D Concentration with Breast Cancer Risk in Postmenopausal Women in the US.

作者信息

Ganji Vijay, Sukik Layan, Hoque Bushra, Boutefnouchet Linda, Shi Zumin

机构信息

Human Nutrition Department, College of Health Sciences, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.

出版信息

J Pers Med. 2022 Jun 9;12(6):944. doi: 10.3390/jpm12060944.

DOI:10.3390/jpm12060944
PMID:35743729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9225599/
Abstract

The association between serum 25-hydroxyvitamin D [25(OH)D] concentration and breast cancer risk in postmenopausal women is not well understood. The aim of this study was to investigate the association between serum 25(OH)D concentration and breast cancer in postmenopausal women in the United States using nationally representative sample surveys. We used the data from seven cycles of National Health and Nutrition Examination Surveys from 2001 to 2014. Participants were non-institutionalized postmenopausal women (n = 8108). In restricted cubic spline analysis, a significant, nonlinear, invert ‘U’ relationship was observed between serum 25(OH)D concentrations and breast cancer in postmenopausal women (p = 0.029). Overall, breast cancer risk was highest (OR = 1.5) between 70 nmol/L and 80 nmol/L of serum 25(OH)D concentration. Then after serum 25(OH)D 80 nmol/L concentration, the breast cancer risk declined. In multivariate-adjusted logistic regression, the risk of having breast cancer was significantly higher in serum 25(OH)D 75−˂100 nmol/L category compared to the 25(OH)D < 30 nmol/L category [OR and 95% CI: 2.4 (1.4−4.0)]. In conclusion, serum vitamin D concentrations ≥ 100 nmol/L are associated with reduced risk of breast cancer in postmenopausal women. Controlled trials are required to verify if serum 25(OH)D ≥ 100 nmol/L offers protection against breast cancer in postmenopausal women.

摘要

绝经后女性血清25-羟基维生素D[25(OH)D]浓度与乳腺癌风险之间的关联尚未完全明确。本研究旨在利用具有全国代表性的样本调查,探究美国绝经后女性血清25(OH)D浓度与乳腺癌之间的关联。我们使用了2001年至2014年七个周期的国家健康与营养检查调查数据。参与者为非机构化的绝经后女性(n = 8108)。在受限立方样条分析中,观察到绝经后女性血清25(OH)D浓度与乳腺癌之间存在显著的非线性倒“U”关系(p = 0.029)。总体而言,血清25(OH)D浓度在70 nmol/L至80 nmol/L之间时,乳腺癌风险最高(OR = 1.5)。在血清25(OH)D浓度达到80 nmol/L之后,乳腺癌风险下降。在多变量调整的逻辑回归分析中,与25(OH)D < 30 nmol/L组相比,血清25(OH)D浓度在75−˂100 nmol/L组患乳腺癌的风险显著更高[OR及95%CI:2.4(1.4−4.0)]。总之,血清维生素D浓度≥100 nmol/L与绝经后女性乳腺癌风险降低相关。需要进行对照试验来验证血清25(OH)D≥100 nmol/L是否能为绝经后女性提供预防乳腺癌的保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/9225599/558f0bb90d5e/jpm-12-00944-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/9225599/87a7cec76871/jpm-12-00944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/9225599/558f0bb90d5e/jpm-12-00944-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/9225599/87a7cec76871/jpm-12-00944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/9225599/558f0bb90d5e/jpm-12-00944-g002a.jpg

相似文献

1
Association of Serum 25-Hydroxyvitamin D Concentration with Breast Cancer Risk in Postmenopausal Women in the US.美国绝经后女性血清25-羟基维生素D浓度与乳腺癌风险的关联
J Pers Med. 2022 Jun 9;12(6):944. doi: 10.3390/jpm12060944.
2
Association of serum 25-hydroxyvitamin D levels with all-cause and cause-specific mortality among postmenopausal females: results from NHANES.血清 25-羟维生素 D 水平与绝经后女性全因及特定原因死亡率的关系:来自 NHANES 的结果。
J Transl Med. 2023 Sep 16;21(1):629. doi: 10.1186/s12967-023-04413-y.
3
Association of serum 25-hydroxy-vitamin D concentration and risk of mortality in cancer survivors in the United States.血清 25-羟维生素 D 浓度与美国癌症幸存者死亡风险的关联。
BMC Cancer. 2024 Apr 30;24(1):545. doi: 10.1186/s12885-024-12304-8.
4
Serum 25-hydroxyvitamin D might be negatively associated with hyperuricemia in U.S. adults: an analysis of the National Health and Nutrition Examination Survey 2007-2014.血清 25-羟维生素 D 可能与美国成年人高尿酸血症呈负相关:对 2007-2014 年全国健康和营养调查的分析。
J Endocrinol Invest. 2022 Apr;45(4):719-729. doi: 10.1007/s40618-021-01637-x. Epub 2021 Aug 26.
5
U-shaped association between serum 25-hydroxyvitamin D concentrations and urinary leakage among adult females aged 45 years and over in the United States: a cross-sectional study.血清 25-羟维生素 D 浓度与美国 45 岁及以上成年女性尿失禁的 U 型关联:一项横断面研究。
BMC Womens Health. 2024 Jan 23;24(1):58. doi: 10.1186/s12905-024-02906-6.
6
L-shaped association of serum 25-hydroxyvitamin D with all-cause and cardiovascular mortality in older people with chronic kidney disease: results from the NHANES database prospective cohort study.血清 25-羟维生素 D 与慢性肾脏病老年人全因和心血管死亡率的 L 型关联:来自 NHANES 数据库前瞻性队列研究的结果。
BMC Public Health. 2023 Jun 28;23(1):1260. doi: 10.1186/s12889-023-16165-x.
7
Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.美国老年成年人血清25-羟维生素D水平、心血管疾病死亡率和全因死亡率的前瞻性研究。
J Am Geriatr Soc. 2009 Sep;57(9):1595-603. doi: 10.1111/j.1532-5415.2009.02359.x. Epub 2009 Jun 22.
8
Vitamin D status, bone mass, and bone metabolism in home-dwelling postmenopausal Japanese women: Yokogoshi Study.居家绝经后日本女性的维生素D状况、骨量和骨代谢:横越研究
Bone. 2008 Feb;42(2):271-7. doi: 10.1016/j.bone.2007.09.056. Epub 2007 Oct 10.
9
Association between Serum 25-Hydroxyvitamin D and Abdominal Aortic Calcification: A Large Cross-Sectional Study.血清 25-羟维生素 D 与腹主动脉钙化的相关性:一项大型横断面研究。
Int J Clin Pract. 2023 Feb 13;2023:1621873. doi: 10.1155/2023/1621873. eCollection 2023.
10
Serum 25-hydroxyvitamin D concentrations and their impact on all-cause mortality in Parkinson's disease: insights from National Health and Nutrition Examination Survey 1999-2020 data.血清25-羟维生素D浓度及其对帕金森病全因死亡率的影响:来自1999 - 2020年美国国家健康与营养检查调查数据的见解
Front Nutr. 2024 Aug 9;11:1423651. doi: 10.3389/fnut.2024.1423651. eCollection 2024.

引用本文的文献

1
Vitamin D's Impact on Cancer Incidence and Mortality: A Systematic Review.维生素D对癌症发病率和死亡率的影响:一项系统综述。
Nutrients. 2025 Jul 16;17(14):2333. doi: 10.3390/nu17142333.
2
Higher red cell distribution width (RDW) is associated with increased all-cause and cardiovascular mortality in patients with breast cancer: A retrospective analysis of NHANES data (1999-2018).较高的红细胞分布宽度(RDW)与乳腺癌患者全因死亡率和心血管死亡率升高相关:对美国国家健康与营养检查调查(NHANES)数据(1999 - 2018年)的回顾性分析
PLoS One. 2025 Jul 28;20(7):e0328680. doi: 10.1371/journal.pone.0328680. eCollection 2025.
3
Vitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial.

本文引用的文献

1
Vitamin D baseline levels at diagnosis of breast cancer: A systematic review and meta-analysis.乳腺癌诊断时维生素 D 基线水平:系统评价和荟萃分析。
Hematol Oncol Stem Cell Ther. 2021 Mar;14(1):16-26. doi: 10.1016/j.hemonc.2020.08.005. Epub 2020 Sep 26.
2
MacroH2A1 Immunoexpression in Breast Cancer.MacroH2A1在乳腺癌中的免疫表达
Front Oncol. 2020 Aug 21;10:1519. doi: 10.3389/fonc.2020.01519. eCollection 2020.
3
Serum Vitamin D Concentration ≥75 nmol/L Is Related to Decreased Cardiometabolic and Inflammatory Biomarkers, Metabolic Syndrome, and Diabetes; and Increased Cardiorespiratory Fitness in US Adults.
乳腺癌新辅助化疗期间补充维生素D可提高病理完全缓解率:一项前瞻性随机临床试验
World J Surg. 2025 Jun;49(6):1396-1405. doi: 10.1002/wjs.12587. Epub 2025 Apr 14.
4
Dual effect of vitamin D on breast cancer-associated fibroblasts.维生素 D 对乳腺癌相关成纤维细胞的双重作用。
BMC Cancer. 2024 Feb 15;24(1):209. doi: 10.1186/s12885-024-11961-z.
5
Calcitriol promotes M2 polarization of tumor-associated macrophages in 4T1 mouse mammary gland cancer via the induction of proinflammatory cytokines.骨化三醇通过诱导促炎细胞因子促进 4T1 小鼠乳腺癌中肿瘤相关巨噬细胞向 M2 极化。
Sci Rep. 2024 Feb 15;14(1):3778. doi: 10.1038/s41598-024-54433-x.
6
Hypovitaminosis D and Metabolic Syndrome in Postmenopausal Women.绝经后女性维生素D缺乏与代谢综合征
Healthcare (Basel). 2022 Oct 14;10(10):2026. doi: 10.3390/healthcare10102026.
7
Modulation of Fibroblast Activity via Vitamin D Is Dependent on Tumor Type-Studies on Mouse Mammary Gland Cancer.通过维生素D调节成纤维细胞活性取决于肿瘤类型——对小鼠乳腺癌的研究
Cancers (Basel). 2022 Sep 21;14(19):4585. doi: 10.3390/cancers14194585.
血清维生素 D 浓度≥75nmol/L 与美国成年人的心血管代谢和炎症生物标志物降低、代谢综合征和糖尿病减少以及心肺功能提高有关。
Nutrients. 2020 Mar 10;12(3):730. doi: 10.3390/nu12030730.
4
Practical approach to diagnosis of bland-looking spindle cell lesions of the breast.乳腺外观平淡的梭形细胞病变的实用诊断方法
Pathologica. 2019 Dec;111(4):344-360. doi: 10.32074/1591-951X-31-19.
5
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
6
Vitamin D intake, blood vitamin D levels, and the risk of breast cancer: a dose-response meta-analysis of observational studies.维生素D摄入量、血液维生素D水平与乳腺癌风险:观察性研究的剂量反应荟萃分析
Aging (Albany NY). 2019 Dec 28;11(24):12708-12732. doi: 10.18632/aging.102597.
7
Poor Vitamin D Status in Active Pulmonary Tuberculosis Patients and Its Correlation with Leptin and TNF-α.活动性肺结核患者维生素D水平低下及其与瘦素和肿瘤坏死因子-α的相关性
J Nutr Sci Vitaminol (Tokyo). 2019;65(5):390-398. doi: 10.3177/jnsv.65.390.
8
Vitamin D receptor expression in invasive breast tumors and breast cancer survival.维生素 D 受体在浸润性乳腺癌肿瘤和乳腺癌生存中的表达。
Breast Cancer Res. 2019 Jul 29;21(1):84. doi: 10.1186/s13058-019-1169-1.
9
The Association between Serum 25-Hydroxyvitamin D and Cancer Risk: Results from the Prospective KORA F4 Study.血清 25-羟维生素 D 与癌症风险的关联:前瞻性 KORA F4 研究结果。
Oncol Res Treat. 2018;41(3):117-121. doi: 10.1159/000485512. Epub 2018 Feb 27.
10
Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women.从未吸烟的绝经后女性血清25-羟基维生素D浓度与肺癌风险
Cancer Causes Control. 2017 Oct;28(10):1053-1063. doi: 10.1007/s10552-017-0956-1. Epub 2017 Sep 12.